Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protease expression in dedifferentiated parosteal osteosarcoma.

C Haeckel1, A G Ayala, K Radig

  • 1Institute of Pathology, Otto-von-Guericke Universtiy, Magdeburg, Germany.

Archives of Pathology & Laboratory Medicine
|March 23, 1999
PubMed
Summary

Dedifferentiated parosteal osteosarcoma shows increased expression of urokinase plasminogen activator (u-PA), its receptor (u-PAR), and cathepsin B. These molecules may contribute to the metastatic potential of these aggressive bone tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors revealed: keratinocyte carcinoma following transplant.

The British journal of dermatology·2017
Same author

Of mice and men: divergent risks of teriparatide-induced osteosarcoma.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2009
Same author

Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases.

Histopathology·2005
Same author

Osteosarcoma of bone in apatient with primary hyperparathyroidism: a case report.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2003
Same author

Ciliated epithelia in the urethra: case report and literature review.

Pathology international·2002
Same author

Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas.

The American journal of surgical pathology·2001

Area of Science:

  • Oncology
  • Biochemistry
  • Pathology

Background:

  • Parosteal osteosarcoma with dedifferentiation serves as a model for tumor progression.
  • Stromal degradation by proteolytic enzymes promotes tumor invasion and metastasis.

Purpose of the Study:

  • To investigate the expression patterns of urokinase plasminogen activator (u-PA), its cell-surface receptor (u-PAR), and cathepsin B in parosteal osteosarcoma and its dedifferentiated form.
  • To understand the role of these molecules in tumor progression and metastatic potential.

Main Methods:

  • Immunohistochemical analysis was performed on 11 parosteal osteosarcoma and 4 dedifferentiated parosteal osteosarcoma cases.
  • Expression levels of u-PA, u-PAR, and cathepsin B were evaluated in tumor cells.

Related Experiment Videos

Main Results:

  • u-PA, u-PAR, and cathepsin B were coexpressed in most tumor cells, with significantly enhanced expression in the dedifferentiated, high-grade component.
  • Tumor cells involved in bone production showed strong expression regardless of grade.
  • Expression was undetectable in normalized cells within well-developed tumor bone trabeculae.

Conclusions:

  • The study indicates that u-PA and its interacting molecules (u-PAR, cathepsin B) may contribute to the metastatic potential of dedifferentiated parosteal osteosarcoma.
  • These findings highlight the potential role of proteolytic enzymes in the aggressiveness of this bone tumor subtype.